Genes associated with hematopoietic cells
Array location . | BM intensity . | ESC intensity . | ESC/BM ratio . | Gene-protein description/name . | GenBank no. . |
|---|---|---|---|---|---|
| D05ef5 | 2 | 0 | ↓ | fms-related tyrosine kinase 3, flt3/flk2 | U02687 |
| F11cd2 | 2 | 0 | ↓ | Tyrosine kinase with immunoglobulin and EGF homology domains, Tie-1 | NM_005424 |
| J21ab6 | 2 | 0 | ↓ | Interleukin-12 receptor, β2 | NM_001559 |
| O11ef7 | 2 | 0 | ↓ | Interleukin-7 receptor | M29696 |
| L20ab4 | 3 | 0 | ↓ | GATA binding protein 2, GATA-2 | NM_002050 |
| M01ab5 | 6 | 0 | ↓ | v-ets erythroblastosis virus E26 oncogene-like (avian), Erg-2 | NM_004449 |
| C01ef6 | 2 | 0 | ↓ | Ras-related C3 botulinum toxin substrate 1, rac | M29870 |
| H06ef5 | 3 | 0 | ↓ | Growth factor receptor-bound protein 2, Grb2 | L29511 |
| J09ef1 | 2 | 0 | ↓ | Phosphoinositide-3-kinase, class 2, β polypeptide, Pl3K | Y11312 |
| E06ef6 | 2 | 0 | ↓ | B-cell CLL/lymphoma 2, BCL2 | M14745 |
| K24ef1 | 47 | 0 | ↓ | BCL2-antagonist of cell death | U66879 |
| B09gh1 | 4 | 0 | ↓ | Bcl-2-associated transcription factor | NM_014739 |
| N04ab6 | 2 | 0 | ↓ | Laminin, α 4 | NM_002290 |
| D15ef7 | 2 | 0 | ↓ | Inhibin, βA (activin A, activin AB alpha polypeptide) | J03634 |
| O24ab7 | 2 | 0 | ↓ | Inhibin, βC | NM_005538 |
| G22gh6 | 2 | 0 | ↓ | Colony-stimulating factor 2 (granulocyte-macrophage), GM-CSF | NM_000758 |
| M24ef7 | 2 | 0 | ↓ | Macrophage stimulating 1 (hepatocyte growth factor-like) | M74178 |
| H02ab7 | 3 | 0 | ↓ | Interferon, α14 | NM_002172 |
| H03ef7 | 4 | 0 | ↓ | Interleukin-13 | L06801 |
| H13ef7 | 5 | 0 | ↓ | Interleukin-15 | U14407 |
| K09ef4 | 2 | 0 | ↓ | Interleukin-26 | NM_018402 |
| O22ef7 | 2 | 0 | ↓ | Interleukin-8 | Y00787 |
| C15cd3 | 2 | 0 | ↓ | Small inducible cytokine A2 (monocyte chemotactic protein 1), CCL2 | NM_002982 |
| E23ef5 | 6 | 0 | ↓ | Small inducible cytokine A7 (monocyte chemotactic protein 3), MCP3 | X72308 |
| F14cd1 | 2 | 0 | ↓ | Small inducible cytokine subfamily B (Cys-Xaa-Cys), member 6, CXCL6 | NM_002993 |
| K22ef7 | 13 | 0 | ↓ | Small inducible cytokine A5 (RANTES) | M21121 |
| M08ef7 | 16 | 0 | ↓ | Small inducible cytokine A1, I-309 | M57502 |
| N08cd6 | 2 | 0 | ↓ | Small inducible cytokine subfamily A (Cys-Cys), member 27, CCL27 | NM_006664 |
| N01ab7 | 7 | 0 | ↓ | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila), MLL | NM_005933 |
| G21ef7 | 77 | 8 | 0.104 | Laminin receptor 1 (67 kDa, ribosomal protein SA) | U43901 |
| G14gh6 | 6 | 2 | 0.333 | Interferon, α2 | NM_000605 |
| N05ef4 | 24 | 10 | 0.417 | Chemokine-like factor 2 | NM_016326 |
| G13ab2 | 4 | 2 | 0.5 | Activin A receptor, type IIB | NM_001106 |
| J01ab7 | 4 | 2 | 0.5 | MAD, mothers against decapentaplegic homolog 5 (Drosophila), SMAD5 | NM_005903 |
| M13cd2 | 3 | 2 | 0.667 | T-cell acute lymphocytic leukemia 1, SCL | NM_003189 |
| G14ab2 | 3 | 2 | 0.667 | Angiopoietin-1 | NM_001146 |
| G16ef5 | 3 | 2 | 0.667 | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, c-kit | X06182 |
| C23ab3 | 50 | 38 | 0.76 | β2-microglobulin | NM_004048 |
| I23ef4 | 43 | 34 | 0.791 | Chemokine-like factor 1 | NM_016951 |
| K23cd4 | 9 | 8 | 0.889 | Mitogen-activated protein kinase-activated protein kinase 3, MAPAPK3 | NM_004635 |
| A10ab3 | 2 | 2 | 1 | Bone morphogenetic protein 7 (osteogenic protein 1), BMP-7 | NM_001719 |
| F02cd1 | 2 | 2 | 1 | Small inducible cytokine subfamily A (Cys-Cys), member 11 (eotaxin), CCL 11 | NM_002986 |
| L23ab2 | 2 | 2 | 1 | Angiopoietin-like 1 | NM_004673 |
| N12ab3 | 2 | 2 | 1 | Bone morphogenetic protein 4, BMP-4 | NM_001202 |
| A05gh1 | 2 | 2 | 1 | Stromal cell—derived factor 2-like 1, SCDF2L1 | NM_022044 |
| G11ab2 | 3 | 4 | 1.333 | Activin A receptor, type II | NM_001616 |
| M01cd1 | 8 | 12 | 1.5 | Nuclear factor (erythroid-derived 2), 45 kDa, Nf-E2 | NM_006163 |
| C18ab6 | 0 | 16 | ↑ | Glycophorin B (includes Ss blood group) | NM_002100 |
| L03ab3 | 0 | 4 | ↑ | CD14 antigen | NM_000591 |
| E21ef7 | 0 | 8 | ↑ | Integrin, β6 | M35198 |
| E21gh1 | 0 | 4 | ↑ | Signal transducer and activator of transcription 5A, Stat5a | NM_003152 |
| G21cd2 | 0 | 4 | ↑ | Signal transducer and activator of transcription 4, Stat4 | NM_003151 |
| B13ef5 | 0 | 6 | ↑ | Mitogen-activated protein kinase 3, MAPK3 | X60188 |
| B19ef5 | 0 | 8 | ↑ | Mitogen-activated protein kinase 4, MAPK4 | X59727 |
| L09ab6 | 0 | 4 | ↑ | Inositol polyphosphate phosphatase-like 1, SHIP-2 | NM_001567 |
| L16ef5 | 0 | 4 | ↑ | Mitogen-activated protein kinase 8, MAPK8 | L26318 |
| N04ef5 | 0 | 4 | ↑ | Janus kinase 2 (a protein tyrosine kinase), JAK2 | AF005216 |
| A08ef7 | 0 | 12 | ↑ | Interleukin-1 receptor, type II | X59770 |
| K08ab5 | 0 | 6 | ↑ | Chemokine (C motif) XC receptor 1 | NM_005283 |
| C03cd8 | 0 | 4 | ↑ | Interleukin-1, δ | NM_012275 |
| L04ef8 | 0 | 4 | ↑ | Fibroblast growth factor 20, FGF-20 | NM_019851 |
| N08ab3 | 0 | 4 | ↑ | Bone morphogenetic protein 1, BMP-1 | NM_001199 |
| P20ab5 | 0 | 4 | ↑ | Epidermal growth factor (β-urogastrone), EGF | NM_001963 |
| P24cd2 | 2 | 4 | 2 | Platelet factor 4 | NM_002619 |
| G09ab2 | 4 | 8 | 2 | Activin A receptor, type IB | NM_004302 |
| F14cd2 | 2 | 6 | 3 | Stromal cell-derived factor 2, SCDF2 | NM_006923 |
| I14ab6 | 2 | 6 | 3 | Integrin, β2 (antigen CD18 [p95]) | NM_000211 |
| M03cd1 | 1 | 4 | 4 | Nuclear factor (erythroid-derived 2)-like 2, Nrf-2 | NM_006164 |
| L18ef4 | 1 | 4 | 4 | Putative leukocyte platelet-activating factor receptor | M76676 |
| O16ef7 | 1 | 4 | 4 | Platelet-derived growth factor alpha polypeptide, PDGF-a | X06374 |
| G24cd7 | 1 | 4 | 4 | Mitogen-activated protein kinase kinase kinase kinase 1, MAP4K1 | NM_007181 |
| B21ef5 | 1 | 6 | 6 | Mitogen-activated protein kinase 7, MAPK7 | U25278 |
| J05ab7 | 1 | 10 | 10 | MAD, mothers against decapentapiegic homolog 9 (Drosophila), SMAD9 | NM_005905 |
| M02ab6 | 11 | 116 | 10.55 | Myeloperoxidase, MPO | NM_000250 |
Array location . | BM intensity . | ESC intensity . | ESC/BM ratio . | Gene-protein description/name . | GenBank no. . |
|---|---|---|---|---|---|
| D05ef5 | 2 | 0 | ↓ | fms-related tyrosine kinase 3, flt3/flk2 | U02687 |
| F11cd2 | 2 | 0 | ↓ | Tyrosine kinase with immunoglobulin and EGF homology domains, Tie-1 | NM_005424 |
| J21ab6 | 2 | 0 | ↓ | Interleukin-12 receptor, β2 | NM_001559 |
| O11ef7 | 2 | 0 | ↓ | Interleukin-7 receptor | M29696 |
| L20ab4 | 3 | 0 | ↓ | GATA binding protein 2, GATA-2 | NM_002050 |
| M01ab5 | 6 | 0 | ↓ | v-ets erythroblastosis virus E26 oncogene-like (avian), Erg-2 | NM_004449 |
| C01ef6 | 2 | 0 | ↓ | Ras-related C3 botulinum toxin substrate 1, rac | M29870 |
| H06ef5 | 3 | 0 | ↓ | Growth factor receptor-bound protein 2, Grb2 | L29511 |
| J09ef1 | 2 | 0 | ↓ | Phosphoinositide-3-kinase, class 2, β polypeptide, Pl3K | Y11312 |
| E06ef6 | 2 | 0 | ↓ | B-cell CLL/lymphoma 2, BCL2 | M14745 |
| K24ef1 | 47 | 0 | ↓ | BCL2-antagonist of cell death | U66879 |
| B09gh1 | 4 | 0 | ↓ | Bcl-2-associated transcription factor | NM_014739 |
| N04ab6 | 2 | 0 | ↓ | Laminin, α 4 | NM_002290 |
| D15ef7 | 2 | 0 | ↓ | Inhibin, βA (activin A, activin AB alpha polypeptide) | J03634 |
| O24ab7 | 2 | 0 | ↓ | Inhibin, βC | NM_005538 |
| G22gh6 | 2 | 0 | ↓ | Colony-stimulating factor 2 (granulocyte-macrophage), GM-CSF | NM_000758 |
| M24ef7 | 2 | 0 | ↓ | Macrophage stimulating 1 (hepatocyte growth factor-like) | M74178 |
| H02ab7 | 3 | 0 | ↓ | Interferon, α14 | NM_002172 |
| H03ef7 | 4 | 0 | ↓ | Interleukin-13 | L06801 |
| H13ef7 | 5 | 0 | ↓ | Interleukin-15 | U14407 |
| K09ef4 | 2 | 0 | ↓ | Interleukin-26 | NM_018402 |
| O22ef7 | 2 | 0 | ↓ | Interleukin-8 | Y00787 |
| C15cd3 | 2 | 0 | ↓ | Small inducible cytokine A2 (monocyte chemotactic protein 1), CCL2 | NM_002982 |
| E23ef5 | 6 | 0 | ↓ | Small inducible cytokine A7 (monocyte chemotactic protein 3), MCP3 | X72308 |
| F14cd1 | 2 | 0 | ↓ | Small inducible cytokine subfamily B (Cys-Xaa-Cys), member 6, CXCL6 | NM_002993 |
| K22ef7 | 13 | 0 | ↓ | Small inducible cytokine A5 (RANTES) | M21121 |
| M08ef7 | 16 | 0 | ↓ | Small inducible cytokine A1, I-309 | M57502 |
| N08cd6 | 2 | 0 | ↓ | Small inducible cytokine subfamily A (Cys-Cys), member 27, CCL27 | NM_006664 |
| N01ab7 | 7 | 0 | ↓ | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila), MLL | NM_005933 |
| G21ef7 | 77 | 8 | 0.104 | Laminin receptor 1 (67 kDa, ribosomal protein SA) | U43901 |
| G14gh6 | 6 | 2 | 0.333 | Interferon, α2 | NM_000605 |
| N05ef4 | 24 | 10 | 0.417 | Chemokine-like factor 2 | NM_016326 |
| G13ab2 | 4 | 2 | 0.5 | Activin A receptor, type IIB | NM_001106 |
| J01ab7 | 4 | 2 | 0.5 | MAD, mothers against decapentaplegic homolog 5 (Drosophila), SMAD5 | NM_005903 |
| M13cd2 | 3 | 2 | 0.667 | T-cell acute lymphocytic leukemia 1, SCL | NM_003189 |
| G14ab2 | 3 | 2 | 0.667 | Angiopoietin-1 | NM_001146 |
| G16ef5 | 3 | 2 | 0.667 | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, c-kit | X06182 |
| C23ab3 | 50 | 38 | 0.76 | β2-microglobulin | NM_004048 |
| I23ef4 | 43 | 34 | 0.791 | Chemokine-like factor 1 | NM_016951 |
| K23cd4 | 9 | 8 | 0.889 | Mitogen-activated protein kinase-activated protein kinase 3, MAPAPK3 | NM_004635 |
| A10ab3 | 2 | 2 | 1 | Bone morphogenetic protein 7 (osteogenic protein 1), BMP-7 | NM_001719 |
| F02cd1 | 2 | 2 | 1 | Small inducible cytokine subfamily A (Cys-Cys), member 11 (eotaxin), CCL 11 | NM_002986 |
| L23ab2 | 2 | 2 | 1 | Angiopoietin-like 1 | NM_004673 |
| N12ab3 | 2 | 2 | 1 | Bone morphogenetic protein 4, BMP-4 | NM_001202 |
| A05gh1 | 2 | 2 | 1 | Stromal cell—derived factor 2-like 1, SCDF2L1 | NM_022044 |
| G11ab2 | 3 | 4 | 1.333 | Activin A receptor, type II | NM_001616 |
| M01cd1 | 8 | 12 | 1.5 | Nuclear factor (erythroid-derived 2), 45 kDa, Nf-E2 | NM_006163 |
| C18ab6 | 0 | 16 | ↑ | Glycophorin B (includes Ss blood group) | NM_002100 |
| L03ab3 | 0 | 4 | ↑ | CD14 antigen | NM_000591 |
| E21ef7 | 0 | 8 | ↑ | Integrin, β6 | M35198 |
| E21gh1 | 0 | 4 | ↑ | Signal transducer and activator of transcription 5A, Stat5a | NM_003152 |
| G21cd2 | 0 | 4 | ↑ | Signal transducer and activator of transcription 4, Stat4 | NM_003151 |
| B13ef5 | 0 | 6 | ↑ | Mitogen-activated protein kinase 3, MAPK3 | X60188 |
| B19ef5 | 0 | 8 | ↑ | Mitogen-activated protein kinase 4, MAPK4 | X59727 |
| L09ab6 | 0 | 4 | ↑ | Inositol polyphosphate phosphatase-like 1, SHIP-2 | NM_001567 |
| L16ef5 | 0 | 4 | ↑ | Mitogen-activated protein kinase 8, MAPK8 | L26318 |
| N04ef5 | 0 | 4 | ↑ | Janus kinase 2 (a protein tyrosine kinase), JAK2 | AF005216 |
| A08ef7 | 0 | 12 | ↑ | Interleukin-1 receptor, type II | X59770 |
| K08ab5 | 0 | 6 | ↑ | Chemokine (C motif) XC receptor 1 | NM_005283 |
| C03cd8 | 0 | 4 | ↑ | Interleukin-1, δ | NM_012275 |
| L04ef8 | 0 | 4 | ↑ | Fibroblast growth factor 20, FGF-20 | NM_019851 |
| N08ab3 | 0 | 4 | ↑ | Bone morphogenetic protein 1, BMP-1 | NM_001199 |
| P20ab5 | 0 | 4 | ↑ | Epidermal growth factor (β-urogastrone), EGF | NM_001963 |
| P24cd2 | 2 | 4 | 2 | Platelet factor 4 | NM_002619 |
| G09ab2 | 4 | 8 | 2 | Activin A receptor, type IB | NM_004302 |
| F14cd2 | 2 | 6 | 3 | Stromal cell-derived factor 2, SCDF2 | NM_006923 |
| I14ab6 | 2 | 6 | 3 | Integrin, β2 (antigen CD18 [p95]) | NM_000211 |
| M03cd1 | 1 | 4 | 4 | Nuclear factor (erythroid-derived 2)-like 2, Nrf-2 | NM_006164 |
| L18ef4 | 1 | 4 | 4 | Putative leukocyte platelet-activating factor receptor | M76676 |
| O16ef7 | 1 | 4 | 4 | Platelet-derived growth factor alpha polypeptide, PDGF-a | X06374 |
| G24cd7 | 1 | 4 | 4 | Mitogen-activated protein kinase kinase kinase kinase 1, MAP4K1 | NM_007181 |
| B21ef5 | 1 | 6 | 6 | Mitogen-activated protein kinase 7, MAPK7 | U25278 |
| J05ab7 | 1 | 10 | 10 | MAD, mothers against decapentapiegic homolog 9 (Drosophila), SMAD9 | NM_005905 |
| M02ab6 | 11 | 116 | 10.55 | Myeloperoxidase, MPO | NM_000250 |
↓ indicates genes with expression levels undetectable in cells from ESCs; and ↑, genes with expression levels undetectable in cells from BM.